v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net income $ 3,525 $ 2,474
Adjustments to net income:    
Depreciation 1,088 884
Amortization of capitalized software 42 41
Stock compensation 236 245
Gains on sales of assets (13) 0
Deferred taxes (66) (137)
Increase (decrease) from changes in:    
Accounts receivable (557) (215)
Inventories 199 (285)
Prepaid expenses and other current assets (7) (16)
Accounts payable and accrued expenses (24) (29)
Accrued compensation (305) (255)
Income taxes payable 116 61
Changes in funded status of retirement plans 7 (27)
Other (18) (32)
Cash flows from operating activities 4,223 2,709
Cash flows from investing activities    
Capital expenditures (1,190) (2,428)
Proceeds from U.S. CHIPS and Science Act (CHIPS Act) incentives 1,104 260
Proceeds from asset sales 37 0
Purchases of short-term investments (3,342) (1,839)
Proceeds from short-term investments 1,679 3,938
Other (37) (13)
Cash flows from investing activities (1,749) (82)
Cash flows from financing activities    
Proceeds from issuance of long-term debt 0 1,199
Repayment of debt 0 (750)
Dividends paid (2,586) (2,473)
Stock repurchases (185) (955)
Proceeds from common stock transactions 754 233
Other (22) (37)
Cash flows from financing activities (2,039) (2,783)
Net change in cash and cash equivalents 435 (156)
Cash and cash equivalents at beginning of period 3,225 3,200
Cash and cash equivalents at end of period 3,660 3,044
Supplemental cash flow information    
Investment tax credit (ITC) used to reduce income taxes payable 301 203
Proceeds from CHIPS Act incentives 1,104 260
Total cash benefit related to the CHIPS Act $ 1,405 $ 463